Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Breast Cancer
Sep 24, 2024, 15:44 |
Blog
Maria Borrero: All things about breast cancer and caring for the Latina women of Utah
Maria Borrero, Hematology/Oncology fellow at the Medical School and School of Public Health at the University…
Sep 24, 2024, 09:22 |
Blog
Matthew Kurian: Joyce O'Shaughnessy about the current landscape and recent updates in breast cancer!
Matthew Kurian, Staff Oncologist at St. Elizabeth Healthcare, shared a post on LinkedIn: "Calling all…
Sep 24, 2024, 09:07 |
Blog
Guilherme Nader Marta: Global study on young BRCA carriers with breast cancer
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared a post by Elisa Agostinetto,…
Sep 24, 2024, 09:03 |
Blog
Vas Narasimhan: US FDA has approved our CDK4/6 inhibitor to reduce risk of recurrence in people with HR+/HER2 early breast cancer
Vas Narasimhan posted on LinkedIn: "I’m proud to share the news that the US FDA…
Sep 23, 2024, 23:39 |
Blog
Updated breast cancer treatment algorithms summarized by Ilana Schlam
Ilana Schlam shared a post on X: "Updated (non-exhaustive) breast cancer treatment algorithms, now including adjuvant…
Sep 23, 2024, 14:23 |
Blog
Tatiana Prowell: Ribociclib is now FDA-approved for stage 2 and 3 hormone receptor positive, HER2 negative breast cancer
Erika Hamilton shared on X by Tatiana Prowell, additing: ''Well isn't this a gift for…
Sep 23, 2024, 14:12 |
Blog
Rasha Aboelhassan: Future plans for HER2-positive breast cancer patients
Rasha Aboelhassan shared on Linkedin: ''One of the best things we get from discussing experts…
Sep 23, 2024, 13:38 |
Blog
Olubukola Ayodele: Addressing the mechanism of Endocrine Resistance in HR+ metastatic breast cancer patients at ESMO 2024
Olubukola Ayodele shared on Linkedin: "I'm thrilled to share that my friend Abeid M. Athman…
Sep 23, 2024, 13:37
#EUHPP Live Webinar on 25 years of breast cancer research: Past, present and future
Pink October is international breast cancer awareness month. On this occasion, the Breast International Group…
Sep 23, 2024, 09:00 |
Insight
Theodoros Kontoulis: Heterogeneity of residual disease (RD) after NACT in breast cancer
Theodoros Kontoulis shared on LinkedIn: “Most viewed in the last 7 days from JAMA Oncology:…
2
3
4
5
6
All:
2516
Posts:
31 - 40
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO 24: 15 Posts Not to Miss From Day 2
Julia Louis-Dreyfus and Breast Cancer: How She Went Against, How She Survived, and More
ASTRO24: 20 Posts Not To Miss From Day 1
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube